{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:15:52Z","timestamp":1783664152777,"version":"3.55.0"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide, with liver metastasis representing the principal cause of death in CRC patients. Current primary treatment options for colorectal cancer liver metastases (CRLM) encompass chemotherapy, radiotherapy, targeted therapy, and immunotherapy. However, the survival rate for CRLM patients remains below 40%. The unique immune\u2212tolerant microenvironment of the liver has recently been recognized as a central driver of metastatic colonization, immune evasion, and therapeutic resistance. This review examines the development of CRLM, with particular emphasis on recent therapeutic advances. It also explores promising research and emerging treatment strategies. A deeper understanding of CRLM pathogenesis and therapeutic progress will enable clinicians to optimize treatment approaches and improve patient outcomes.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1861130","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:39:02Z","timestamp":1783661942000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Colorectal cancer liver metastases: mechanism and therapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Shan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuxian","family":"Ban","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong","place":["Hong Kong, China"]},{"name":"Clinical Oncology Center, Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, The University of Hong Kong-Shenzhen Hospital","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutian","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Man","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinjie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000217629.94941.cf","article-title":"Epidemiology and management of liver metastases from colorectal cancer","volume":"244","author":"Manfredi","year":"2006","journal-title":"Ann Surg"},{"key":"B3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12885-019-5515-6","article-title":"Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial","volume":"19","author":"Buisman","year":"2019","journal-title":"BMC Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1633315","article-title":"Immune microenvironment regulation and clinical immunotherapy strategies of metastatic liver cancer","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1503063","article-title":"The liver\u2019s dilemma: sensing real danger in a sea of PAMPs: the (arterial) sinusoidal segment theory","volume":"15","author":"Henriques-Pons","year":"2024","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/egastro-2025-100257","article-title":"Regulatory T cells in liver metastases: emerging and divergent roles in tumour progression","volume":"3","author":"Wu","year":"2025","journal-title":"eGastroenterology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1081585","article-title":"Emerging mechanisms progress of colorectal cancer liver metastasis","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.6","article-title":"Pre-metastatic niches: organ-specific homes for metastases","volume":"17","author":"Peinado","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102418","article-title":"Liver immune microenvironment and metastasis from colorectal cancer-pathogenesis and therapeutic perspectives","volume":"13","author":"Zeng","year":"2021","journal-title":"Cancers"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J Physiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-020-03705-x","article-title":"Matrix metalloproteinase-8 (MMP-8) regulates the activation of hepatic stellate cells (HSCs) through the ERK-mediated pathway","volume":"467","author":"Naim","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103712","article-title":"The extracellular matrix in colorectal cancer and its metastatic settling - alterations and biological implications","volume":"175","author":"Karlsson","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030598","article-title":"The matrix stiffness coordinates the cell proliferation and PD-L1 expression via YAP in lung adenocarcinoma","volume":"16","author":"Park","year":"2024","journal-title":"Cancers"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1386772","article-title":"Vessel co-option: a unique vascular-immune niche in liver cancer","volume":"14","author":"Yang","year":"2024","journal-title":"Front Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-026-04458-3","article-title":"Biomimetic nanodecoys remodel the mechano-immune microenvironment to potentiate checkpoint blockade in colorectal cancer","volume":"527","author":"Wang","year":"2026","journal-title":"J Nanobiotechnol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122900","article-title":"Matrix stiffening from collagen fibril density and alignment modulates YAP-mediated T-cell immune suppression","volume":"315","author":"Sapudom","year":"2025","journal-title":"Biomaterials"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.887380","article-title":"Cancer associated fibroblasts - an impediment to effective anti-cancer T cell immunity","volume":"13","author":"Koppensteiner","year":"2022","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","article-title":"Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer","volume":"14","author":"Zhang","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00821-z","article-title":"Friend or foe? The elusive role of hepatic stellate cells in liver cancer","volume":"20","author":"Cogliati","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146987","article-title":"Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts","volume":"131","author":"Bhattacharjee","year":"2021","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000207","article-title":"The evolving role of liver sinusoidal endothelial cells in liver health and disease","volume":"78","author":"McConnell","year":"2023","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0038-z","article-title":"Every step of the way: integrins in cancer progression and metastasis","volume":"18","author":"Hamidi","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23375","article-title":"E-selectin regulates gene expression in metastatic colorectal carcinoma cells and enhances HMGB1 release","volume":"123","author":"Aychek","year":"2008","journal-title":"Int J Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0020-y","article-title":"Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity","volume":"15","author":"Shetty","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI157937","article-title":"In situ expansion and reprogramming of Kupffer cells elicit potent tumoricidal immunity against liver metastasis","volume":"133","author":"Liu","year":"2023","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2025.101174","article-title":"High metastatic tumor-derived CXCL16 mediates liver colonization metastasis by inducing Kupffer cell polarization via the PI3K\/AKT\/FOXO3a pathway","volume":"65","author":"Liu","year":"2025","journal-title":"Neoplasia"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202504929","article-title":"Viral-directed augmentation of Kupffer cell cross-presentation provokes antitumor immunity against liver metastasis","volume":"12","author":"Chen","year":"2025","journal-title":"Adv Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1186\/s12967-025-07376-4","article-title":"The hepatic macrophage: a key regulator of liver metastatic tumor microenvironment through cell crosstalk","volume":"23","author":"Wang","year":"2025","journal-title":"J Transl Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-0014","article-title":"M2 macrophage-derived exosomes promote cell migration and invasion in colon cancer","volume":"79","author":"Lan","year":"2019","journal-title":"Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13045-020-00991-2","article-title":"Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer","volume":"13","author":"Zhao","year":"2020","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1039\/d5md00897b","article-title":"Kupffer cell M2-like polarization increases liver metastatic burden via the uptake of exosomal KRAS mutant protein from hypoxic colorectal carcinoma cells","volume":"17","author":"You","year":"2025","journal-title":"RSC Med Chem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-25-0031","article-title":"Tissue-specific immunosuppressive and proliferating macrophages fuel early metastatic progression of human colorectal cancer to the liver","volume":"13","author":"Marzano","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2668-9","article-title":"Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases","volume":"20","author":"Katz","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3173","article-title":"TNF receptor-2 facilitates an immunosuppressive microenvironment in the liver to promote the colonization and growth of hepatic metastases","volume":"75","author":"Ham","year":"2015","journal-title":"Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13045-017-0430-2","article-title":"Tumor-associated macrophages: from basic research to clinical application","volume":"10","author":"Yang","year":"2017","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00534-2","article-title":"Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis","volume":"18","author":"Zeng","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41419-019-1922-5","article-title":"The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1-STAT3 signaling pathway","volume":"10","author":"Lin","year":"2019","journal-title":"Cell Death Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903275","article-title":"Tim-3\/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells","volume":"185","author":"Dardalhon","year":"2010","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00488-4","article-title":"Profiling the heterogeneity of colorectal cancer consensus molecular subtypes using spatial transcriptomics","volume":"8","author":"Valdeolivas","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/path.4383","article-title":"Wnt\/\u03b2-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4","volume":"234","author":"Lee","year":"2014","journal-title":"J Pathol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13046-020-01690-z","article-title":"TM4SF1 promotes EMT and cancer stemness via the Wnt\/\u03b2-catenin\/SOX2 pathway in colorectal cancer","volume":"39","author":"Tang","year":"2020","journal-title":"J Exp Clin Cancer Res CR"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28347","article-title":"Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases","volume":"119","author":"Karagkounis","year":"2013","journal-title":"Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030428","article-title":"The role of KRAS mutations in colorectal cancer: biological insights, clinical implications, and future therapeutic perspectives","volume":"17","author":"Takeda","year":"2025","journal-title":"Cancers"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092201","article-title":"Targeting BRAF and RAS in colorectal cancer","volume":"13","author":"Bellio","year":"2021","journal-title":"Cancers"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61030408","article-title":"A narrative review of RAS mutations in early-stage colorectal cancer: mechanisms and clinical implications","volume":"61","author":"Yildirim","year":"2025","journal-title":"Med (Mex)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.616837","article-title":"Direct and indirect modulation of T cells by VEGF-A counteracted by anti-angiogenic treatment","volume":"12","author":"Bourhis","year":"2021","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03254-6","article-title":"ctDNA-based molecular residual disease and survival in resectable colorectal cancer","volume":"30","author":"Nakamura","year":"2024","journal-title":"Nat Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202402730","article-title":"A consensus molecular subtypes classification strategy for clinical colorectal cancer tissues","volume":"7","author":"de Back","year":"2024","journal-title":"Life Sci Alliance"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15107","article-title":"Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer","volume":"8","author":"Isella","year":"2017","journal-title":"Nat Commun"},{"key":"B52","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1038\/s41467-018-07810-w","article-title":"Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis","volume":"9","author":"Zeng","year":"2018","journal-title":"Nat Commun"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2025.110625","article-title":"Exosomal FGG promotes colorectal cancer liver metastases through inducing angiogenic pre-metastatic niche formation","volume":"774","author":"Yang","year":"2025","journal-title":"Arch Biochem Biophys"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20009","article-title":"Circulating exosomal microRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer","volume":"8","author":"Takano","year":"2017","journal-title":"Oncotarget"},{"key":"B55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13046-020-01816-3","article-title":"Exosomal ANGPTL1 attenuates colorectal cancer liver metastasis by regulating Kupffer cell secretion pattern and impeding MMP9 induced vascular leakiness","volume":"40","author":"Jiang","year":"2021","journal-title":"J Exp Clin Cancer Res CR"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgy115","article-title":"Colorectal cancer-derived small extracellular vesicles establish an inflammatory premetastatic niche in liver metastasis","volume":"39","author":"Shao","year":"2018","journal-title":"Carcinogenesis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321187","article-title":"Exosomes derived from Fusobacterium nucleatum-infected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR-1246\/92b-3p\/27a-3p and CXCL16","volume":"70","author":"Guo","year":"2021","journal-title":"Gut"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2025.102706","article-title":"Revisiting tryptophan metabolism in cancer: complexity, context, and spatial heterogeneity","volume":"98","author":"Xu","year":"2026","journal-title":"Curr Opin Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1524651","article-title":"Targeting the kynurenine pathway: another therapeutic opportunity in the metabolic crosstalk between cancer and immune cells","volume":"14","author":"Kang","year":"2024","journal-title":"Front Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70703","article-title":"The kynurenine pathway and indole pathway in tryptophan metabolism influence tumor progression","volume":"14","author":"Lu","year":"2025","journal-title":"Cancer Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"18741","DOI":"10.1038\/s41598-025-03446-1","article-title":"Metabolomic reprogramming of the tumor microenvironment by dual arginase inhibitor OATD-02 boosts anticancer immunity","volume":"15","author":"Grzybowski","year":"2025","journal-title":"Sci Rep"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-025-02178-8","article-title":"Targeting lactylation reinforces NK cell cytotoxicity within the tumor microenvironment","volume":"26","author":"Jin","year":"2025","journal-title":"Nat Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s40164-025-00719-3","article-title":"Lactate and lactylation in cancer: drivers of immune suppression and microenvironmental reprogramming","volume":"14","author":"Ji","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1186\/s12967-025-07272-x","article-title":"Lactate at the crossroads of tumor metabolism and immune escape: a new frontier in cancer therapy","volume":"23","author":"Dong","year":"2025","journal-title":"J Transl Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41590-024-02068-5","article-title":"The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer","volume":"26","author":"He","year":"2025","journal-title":"Nat Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01365-9","article-title":"IL33-induced lipid droplet formation in mature low-density neutrophils drives colorectal cancer liver metastasis","volume":"22","author":"Zhang","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218450","article-title":"Targeting the aHSC-PGE2-NK cell axis overcomes immunosuppression and inhibits liver metastasis in fibrotic liver","volume":"652","author":"Tang","year":"2026","journal-title":"Cancer Lett"},{"key":"B68","doi-asserted-by":"publisher","first-page":"7498","DOI":"10.1038\/s41598-017-07685-9","article-title":"Oleate but not stearate induces the regulatory phenotype of myeloid suppressor cells","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.4062\/biomolther.2020.160","article-title":"Inhibition of COX-2 impairs colon cancer liver metastasis through reduced stromal cell reaction","volume":"29","author":"Herrero","year":"2021","journal-title":"Biomol Ther"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-1409","article-title":"PLT012, a humanized CD36-blocking antibody, is effective for unleashing antitumor immunity against liver cancer and liver metastasis","volume":"15","author":"Tzeng","year":"2025","journal-title":"Cancer Discov"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c02428","article-title":"Metal-phenolic nanomedicines regulate T-cell antitumor function for sono-metabolic cancer therapy","volume":"17","author":"Yan","year":"2023","journal-title":"ACS Nano"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007349","article-title":"MCT4 blockade increases the efficacy of immune checkpoint blockade","volume":"11","author":"Babl","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B73","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40425-017-0308-4","article-title":"Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment","volume":"5","author":"Steggerda","year":"2017","journal-title":"J Immunother Cancer"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/jso.28007","article-title":"Recurrence timing and risk following curative resection of colorectal liver metastases: insights from a hazard function analysis","volume":"131","author":"Kawashima","year":"2025","journal-title":"J Surg Oncol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.121","article-title":"Benefits of multi-disciplinary treatment strategy on survival of patients with colorectal cancer liver metastasis","volume":"10","author":"Lv","year":"2020","journal-title":"Clin Transl Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70097","article-title":"Liver-directed therapies for colorectal liver metastases","volume":"131","author":"Folkerts","year":"2025","journal-title":"Cancer"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2021.2008025","article-title":"Irreversible electroporation for colorectal cancer liver metastasis: a review","volume":"39","author":"Koethe","year":"2022","journal-title":"Int J Hyperth Off J Eur Soc Hyperthermic Oncol North Am Hyperth Group"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-017-5273-2","article-title":"Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival","volume":"28","author":"Calandri","year":"2018","journal-title":"Eur Radiol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2023.12.006","article-title":"Safety and feasibility of establishing an adjuvant hepatic artery infusion program","volume":"26","author":"Janczewski","year":"2024","journal-title":"HPB"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2019.10.004","article-title":"Spatially fractionated radiation therapy: History, present and the future","volume":"20","author":"Yan","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.66.1181","article-title":"SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer","volume":"34","author":"van Hazel","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.9930","article-title":"Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study","volume":"26","author":"Saltz","year":"2008","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.3183","article-title":"Efficacy and tolerability of first-line cetuximab plus leucovorin, fluorouracil, and oxaliplatin (FOLFOX-4) versus FOLFOX-4 in patients with RAS wild-type metastatic colorectal cancer: the open-label, randomized, phase III TAILOR trial","volume":"36","author":"Qin","year":"2018","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2025.2477192","article-title":"State of the art of the molecular hyperselection to guide treatment with anti-EGFR antibodies in RAS WT mCRC: implications for clinical practice and future perspectives","volume":"25","author":"Garc\u00eda-Alfonso","year":"2025","journal-title":"Expert Opin Biol Ther"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252011071","article-title":"Multigene panel next-generation sequencing techniques in the management of patients with metastatic colorectal carcinoma: the way forward for personalized treatment? A single-center experience","volume":"25","author":"Matteucci","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B87","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40265-025-02253-2","article-title":"Targeting HER2 in metastatic colorectal cancer: current therapies, biomarker refinement, and emerging strategies","volume":"86","author":"Vaghi","year":"2026","journal-title":"Drugs"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512030","article-title":"Targeting KRAS in colorectal cancer: A bench to bedside review","volume":"24","author":"Bteich","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103483","article-title":"Systemic treatment of mismatch repair deficient\/microsatellite instability-high metastatic colorectal cancer-single versus double checkpoint inhibition","volume":"9","author":"Marinelli","year":"2024","journal-title":"ESMO Open"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N Engl J Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01015","article-title":"First-line nivolumab plus low-dose ipilimumab for microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer: the phase II checkMate 142 study","volume":"40","author":"Lenz","year":"2022","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051395","article-title":"A review of translational research for targeted therapy for metastatic colorectal cancer","volume":"15","author":"Ruff","year":"2023","journal-title":"Cancers"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27062689","article-title":"Single-cell multi-tissue T cell clonal dynamics reveal distinct immune coercion landscapes in MSI and MSS colorectal cancer","volume":"27","author":"Zhan","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7105","article-title":"Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: A randomized clinical trial","volume":"317","author":"Venook","year":"2017","journal-title":"JAMA"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.03.010","article-title":"Phase I escalating-dose trial of CAR-T therapy targeting CEA+ Metastatic colorectal cancers","volume":"25","author":"C","year":"2017","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"B96","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00262-026-04344-9","article-title":"Clinical and immunological implications of lymphocyte-activation gene 3 expression in metastatic colorectal cancer","volume":"75","author":"Huang","year":"2026","journal-title":"Cancer Immunol Immunother CII"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13096","article-title":"Macrophage-derived extracellular vesicle-packaged WNTs rescue intestinal stem cells and enhance survival after radiation injury","volume":"7","author":"Saha","year":"2016","journal-title":"Nat Commun"},{"key":"B98","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41392-023-01384-w","article-title":"Colorectal cancer-derived extracellular vesicles induce liver premetastatic immunosuppressive niche formation to promote tumor early liver metastasis","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2016.1219815","article-title":"Exosomes secreted from human colon cancer cells influence the adhesion of neighboring metastatic cells: Role of microRNA-210","volume":"17","author":"Bigagli","year":"2016","journal-title":"Cancer Biol Ther"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.201","article-title":"Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer","volume":"113","author":"Matsumura","year":"2015","journal-title":"Br J Cancer"},{"key":"B101","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12943-019-1019-x","article-title":"CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer","volume":"18","author":"Hu","year":"2019","journal-title":"Mol Cancer"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0254-z","article-title":"Exosomes from BM-MSCs increase the population of CSCs via transfer of miR-142-3p","volume":"119","author":"Li","year":"2018","journal-title":"Br J Cancer"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000001762","article-title":"The american society of colon and rectal surgeons clinical practice guidelines for the management of rectal cancer","volume":"63","author":"You","year":"2020","journal-title":"Dis Colon Rectum"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2019.04.014","article-title":"Circulating exosomal miR-141-3p and miR-375 in metastatic progression of rectal cancer","volume":"12","author":"Meltzer","year":"2019","journal-title":"Transl Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1861130\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:39:03Z","timestamp":1783661943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1861130\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":104,"alternative-id":["10.3389\/fimmu.2026.1861130"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1861130","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"article-number":"1861130"}}